Home / Inspections / 1325168

FDA Inspection 1325168 — Carter BloodCare

Carter BloodCare — FEI 3000717800

The FDA completed an inspection of Carter BloodCare on June 24, 2026 in Flower Mound, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Flower Mound, TX (United States)

Facility

Other inspections at this facility

  • 1100120 (NAI Fri Aug 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023643 (NAI Wed Jul 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931289 (NAI Fri Jun 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 808008 (NAI Fri Nov 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694671 (VAI Fri Oct 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources